๐
Vantobra (previously Tobramycin PARI)
tobramycin
Respiratory Tract Infections;Cystic Fibrosis
โ
Authorised
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Vantobra is indicated for the management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients aged 6 years and older with cystic fibrosis (CF). Consideration should be given to official guidance on the appropriate use of antibacterial agents.
โ ๏ธ Patient safety
No